Insider · CIK 0001664690
Charles A. Deignan
Files at CLSD (Clearside Biomedical, Inc.). First filing -, latest -.
In brief
Charles A. Deignan files SEC Form 4 as CFO at CLSD (Clearside Biomedical, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Charles A. Deignan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 8, 2025 | CLSD Clearside Biomedical, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Jan 10, 2025 |
Questions about Charles A. Deignan
Answered from the filings on this page, as of the latest one.
Is Charles A. Deignan buying or selling?
Charles A. Deignan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Charles A. Deignan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Charles A. Deignan has 0.
Where does Charles A. Deignan file Form 4?
Charles A. Deignan has filed Form 4 at CLSD (Clearside Biomedical, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.